India’s Not So Sweet WTO Sugar Story

By Shalini Bhutani | Commentary | December 18, 2020

On December 16, 2020, the Union Cabinet Committee on Economic Affairs (CCEA) approved a subsidy of Rs.35 billion to sugar mills for the export of 60 lakh tonnes of sugar during the October 2020-September 2021 season. In 2018 and 2019, the Government of India had approved the sugar export incentive before October 1, but…

What Does India’s Exit from RCEP Indicate?

By Biswajit Dhar | Commentary | December 7, 2020

On November 15, 2020, 15 East Asian countries agreed to take their economic integration several notches higher by forging the Regional Comprehensive Economic Partnership (RCEP), the largest free trade agreement (FTA) ever. In 2019, RCEP members accounted for about 30 percent of world output and population and 28 percent of world trade. But about…

Corporate-owned Banks: An Idea Whose Time Has Not Yet Come

By Kavaljit Singh | Briefing Paper # 43 | November 30, 2020

On November 20, the Reserve Bank of India released the Report the Internal Working Group (IWG) that reviewed the existing licensing and regulatory guidelines relating to ownership, control, and corporate structure of private sector banks in India. The working group’s most significant but contentious recommendation is to allow large corporate and industrial houses to…

The PLI Scheme for Atmanirbhar Bharat: Is There a Break with Past Policies?

By Smitha Francis | Commentary | November 24, 2020

One of the integral components of the economic stimulus packages announced by the Indian government since April 2020 is the Production-Linked Incentive (PLI) scheme meant to increase India’s self-reliance in key manufacturing sectors. To eligible companies, the scheme offers an incentive of 4% to 6% on their incremental sales of goods manufactured in India…

India and South Africa’s Proposal for a Waiver on Global IPR Laws: What it Means? Why it is Imperative?

By Biswajit Dhar and KM Gopakumar | Briefing Paper # 42 | November 4, 2020

Access to medicines at prices that the patients can afford has been a recurrent concern for the global community ever since the Agreement on Trade Related Aspects of Intellectual Property (TRIPS) was adopted as one of the covered agreements under the World Trade Organization (WTO). The TRIPS Agreement is a charter for…